Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.62 |
| ▸ | LMNA | P02545 | 3/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.62 |
| ▸ | FUT7 | Q11130 | 2/20 | 0.62 |
| ▸ | CA12 | O43570 | 1/20 | 0.62 |
| ▸ | CA1 | P00915 | 1/20 | 0.62 |
| ▸ | CA2 | P00918 | 1/20 | 0.62 |
| ▸ | TP53 | P04637 | 1/20 | 0.62 |
| ▸ | CA3 | P07451 | 1/20 | 0.62 |
| ▸ | SELL | P14151 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | SELP | P16109 | 1/20 | 0.62 |
| ▸ | FUT4 | P22083 | 1/20 | 0.62 |
| ▸ | CA4 | P22748 | 1/20 | 0.62 |
| ▸ | CA6 | P23280 | 1/20 | 0.62 |
| ▸ | DPP4 | P27487 | 1/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | CA5A | P35218 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gallic Acid SCHEMBL28200674 | 0.80 | CA12 (0.94) | KDM4ELMNATDP1ALDH1A1MAPT | |
| SCHEMBL561936 | 0.79 | PTGS2 (0.71) | KDM4ELMNATDP1ALDH1A1FUT7 | |
| SCHEMBL352369 | 0.79 | KDM4E (0.65) | KDM4ELMNATDP1ALDH1A1MAPT | |
| Gallic Acid SCHEMBL617137 | 0.78 | KDM4E (0.56) | KDM4ELMNATDP1ALDH1A1MAPT | |
| Gallic Acid SCHEMBL15012 | 0.77 | CA12 (1.00) | KDM4ELMNATDP1ALDH1A1MAPT | |
| Gallic Acid SCHEMBL1845406 | 0.77 | CA12 (1.00) | KDM4ELMNATDP1ALDH1A1MAPT | |
| Gallic Acid SCHEMBL30375631 | 0.77 | CA12 (1.00) | KDM4ELMNATDP1ALDH1A1MAPT | |
| Gallic Acid SCHEMBL4918056 | 0.77 | CA12 (1.00) | KDM4ELMNATDP1ALDH1A1MAPT | |
| Gallic Acid SCHEMBL678990 | 0.77 | CA12 (1.00) | KDM4ELMNATDP1ALDH1A1MAPT | |
| Gallic Acid SCHEMBL8088102 | 0.77 | CA12 (1.00) | KDM4ELMNATDP1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240197722-A1 | ANTICANCER COMPOSITION INDUCING CELL SENESCENCE AND CELL DEATH | OSTEONEUROGEN INC. (KR) | 2024-06-20 | — | — | US | claimed |
| EP-4327811-A1 | ANTICANCER COMPOSITION INDUCING CELL SENESCENCE AND CELL DEATH | Osteoneurogen Inc. (KR) | 2024-02-28 | — | — | EP | claimed |
| CN-117157074-A | Anticancer composition for inducing cell aging and cell death | 欧斯特奥纽罗根有限公司 | 2023-12-01 | — | — | CN | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| WO-2022225259-A1 | ANTICANCER COMPOSITION INDUCING CELL SENESCENCE AND CELL DEATH | (주)오스티오뉴로젠 | 2022-10-27 | — | — | WO | claimed |
| EP-3760626-B1 | NOVEL COMPOUND AND COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING FIBROSIS OR NONALCOHOLIC STEATOHEPATITIS COMPRISING SAME AS ACTIVE INGREDIENT | OSTEONEUROGEN INC (KR) | 2022-05-18 | — | — | EP | claimed |
| US-11298353-B2 | Anti-inflammatory composition | OSTEONEUROGEN INC. (KR) | 2022-04-12 | — | — | US | claimed |
| CN-106978350-B | Aspergillus niger and application thereof in preparation of puerarin compounds | 北京大学 | 2022-01-07 | — | — | CN | claimed |
| WO-2021158575-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| WO-2021158573-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| US-20100267823-A1 | AURONES AS SELECTIVE PDE INHIBITORS AND THEIR USE IN NEUROLOGICAL CONDITIONS AND DISORDERS | BIOTROPICS MALAYSIA BERHAD (MY) | 2010-10-21 | — | — | US | claimed |
| WO-2010110647-A1 | AURONES AS ESTROGEN RECEPTOR MODULATORS AND THEIR USE IN SEX HORMONE DEPENDENT DISEASES | BIOTROPICS MALAYSIA BERHAD (MY) | 2010-09-30 | — | — | WO | claimed |
| WO-2010110646-A1 | AURONES AS SELECTIVE PDE INHIBITORS AND THEIR USE IN NEUROLOGICAL CONDITIONS AND DISORDERS | BIOTROPICS MALAYSIA BERHAD (MY) | 2010-09-30 | — | — | WO | claimed |
| US-7122573-B2 | Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agents | SRI INTERNATIONAL (US) | 2006-10-17 | — | — | US | claimed |
| US-7109236-B2 | Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agents | SRI INTERNATIONAL (US) | 2006-09-19 | — | — | US | claimed |
| EP-1581512-A2 | ANALOGS OF GREEN TEA POLYPHENOLS AS CHEMOTHERAPEUTIC AND CHEMOPREVENTIVE AGENTS | SRI INTERNATIONAL (US) | 2005-10-05 | — | — | EP | claimed |
| US-20040192723-A1 | Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agents | SRI INTERNATIONAL | 2004-09-30 | — | — | US | claimed |
| WO-2004052873-A9 | ANALOGS OF GREEN TEA POLYPHENOLS AS CHEMOTHERAPEUTIC AND CHEMOPREVENTIVE AGENTS | STANFORD RES INST INT (US) | 2004-08-12 | — | — | WO | claimed |
| WO-2004052873-A2 | ANALOGS OF GREEN TEA POLYPHENOLS AS CHEMOTHERAPEUTIC AND CHEMOPREVENTIVE AGENTS | SRI INTERNATIONAL (US) | 2004-06-24 | — | — | WO | claimed |
| US-20040110790-A1 | Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agents | SRI INTERNATIONAL | 2004-06-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | KDM4E 4637/4885LMNA 344/4885TDP1 3469/4885 |
| US-20040192723-A1 | Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agents | TEAD4, TEAD3, TEAD1 | KDM4E 1321/4885LMNA 3961/4885TDP1 523/4885 |
| US-20040110790-A1 | Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agents | TEAD4, TEAD3, TEAD1 | KDM4E 1321/4885LMNA 3961/4885TDP1 523/4885 |
| US-20240197722-A1 | ANTICANCER COMPOSITION INDUCING CELL SENESCENCE AND CELL DEATH | TP53, CASP3, BAX | KDM4E 3375/4885LMNA 364/4885TDP1 362/4885 |
| US-11298353-B2 | Anti-inflammatory composition | CCL2, CCL5, CCL11 | KDM4E 4455/4885LMNA 3620/4885TDP1 3215/4885 |
| US-20100267823-A1 | AURONES AS SELECTIVE PDE INHIBITORS AND THEIR USE IN NEUROLOGICAL CONDITIONS AND DISORDERS | PDE12, PDE3A, PDE7A | KDM4E 1546/4885LMNA 2114/4885TDP1 25/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.